Package 55513-207-01

{"route": ["INTRAVENOUS"], "spl_id": "7fa722d1-29fa-4771-9fe5-5c8c74cf2673", "openfda": {"nui": ["N0000193543", "N0000178291", "N0000193542"], "unii": ["2S9ZZM9Q9V"], "rxcui": ["2046140", "2046145", "2046148", "2046149"], "spl_set_id": ["0a562b4e-67ce-4bab-852c-d9ee71e55fb8"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]", "Vascular Endothelial Growth Factor Inhibitors [MoA]"], "manufacturer_name": ["Amgen Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (55513-207-01)  / 16 mL in 1 VIAL", "package_ndc": "55513-207-01", "marketing_start_date": "20180601"}, {"sample": false, "description": "1 VIAL in 1 CARTON (55513-207-21)  / 16 mL in 1 VIAL", "package_ndc": "55513-207-21", "marketing_start_date": "20250627"}], "brand_name": "MVASI", "product_id": "55513-207_7fa722d1-29fa-4771-9fe5-5c8c74cf2673", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]", "Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]"], "product_ndc": "55513-207", "generic_name": "bevacizumab-awwb", "labeler_name": "Amgen Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "MVASI", "active_ingredients": [{"name": "BEVACIZUMAB", "strength": "400 mg/16mL"}], "application_number": "BLA761028", "marketing_category": "BLA", "marketing_start_date": "20180601", "listing_expiration_date": "20261231"}